JANUARY ROBINSON: Open Payments
NPI 1255516480 · JOLIET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 34 payments from 13 companies in 2025. Trend: 2023 $1,544 · 2024 $1,218 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $225 |
| Janssen Pharmaceuticals, Inc | 6 | $153 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Alkermes, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Lundbeck LLC | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Corium, LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: VRAYLAR, SPRAVATO, Auvelity, ARISTADA, ABILIFY ASIMTUFII, REXULTI, TRINTELLIX, Qelbree.
Industry payments across IL — which companies pay providers there.
